Gastrointestinal manifestations of systemic sclerosis (scleroderma).
Nearly 90 percent of patients with systemic sclerosis (scleroderma) have some degree of gastrointestinal (GI) involvement, with approximately one-half being symptomatic. Severe GI problems, including malabsorption and intestinal pseudoobstruction, are much less common, affecting less than 10 percent of patients during the first nine years of illness. Stephanie A Kaye-Barrett, MD. UpToDate for Patients. April, 2010. (Also see: GI Involvement)
This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
Gastrointestinal manifestations of systemic sclerosis (scleroderma)
No replies to this topic